Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129803 · ClinicalTrials.gov registry record · NA
Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02129803: Completed NA study, sponsored by Virginia Commonwealth University.
NCT02129803 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02129803, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
Primary Outcome
The Cystic Fibrosis Questionnaire-Revised (CFQ-R) is a validated health-related quality of life measure for CF that meets US Food and Drug Administration psychometric requirements for patient reported outcomes. It contains both generic and CF-specific scales and has demonstrated responsiveness in previous clinical studies. Scores range from 0 to 100 with higher scores indicating better health.
Interventions
- DEVICE High-Flow, 20 LPM (via Optiflow cannula)
- DEVICE Low FLow, 5 LPM (via Optiflow cannula)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-05-29 |
| Phase | NA |
What the finished NCT02129803 record still lists
NCT02129803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which High-Flow, 20 LPM (via Optiflow cannula) is the first listed.
NCT02129803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02129803 about?
NCT02129803 is a clinical study titled "Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis". This study is a single center, randomized pilot study to evaluate the clinical effectiveness of nasal high flow 20LPM humidification therapy in subjects with Cystic Fibrosis.
What is the current status of trial NCT02129803?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-05. Estimated completion is 2019-05-29.
What interventions are being tested in trial NCT02129803?
The interventions under investigation include: High-Flow, 20 LPM (via Optiflow cannula) (DEVICE), Low FLow, 5 LPM (via Optiflow cannula) (DEVICE).
Who is sponsoring clinical trial NCT02129803?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02129803's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia